Aggressive control measures for resistant Acinetobacter baumannii and the impact on acquisition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a medical intensive care unit

Marc-Oliver Wright; Joan N Hebden; Anthony D Harris; Carl B Shanholtz; Harold C Standiford; Jon P Furuno; Eli N Perencevich

doi:10.1086/502370

Aggressive control measures for resistant Acinetobacter baumannii and the impact on acquisition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a medical intensive care unit

Infect Control Hosp Epidemiol. 2004 Feb;25(2):167-8. doi: 10.1086/502370.

Authors

Marc-Oliver Wright¹, Joan N Hebden, Anthony D Harris, Carl B Shanholtz, Harold C Standiford, Jon P Furuno, Eli N Perencevich

Affiliation

¹ Infection Control/Hospital Epidemiology, University of Maryland Medical Center, Baltimore, USA.

PMID: 14994945
DOI: 10.1086/502370

Abstract

The medical ICU implemented aggressive control measures following an outbreak of multidrug-resistant, clonal Acinetobacter baumannii. Multivariable regression analyses comparing acquisition (6 months preceding to 6 months during or following the outbreak) revealed decreased VRE and MRSA acquisition. Aggressive control measures can reduce VRE, and perhaps MRSA, transmission.

MeSH terms

Acinetobacter / drug effects
Acinetobacter / isolation & purification*
Acinetobacter Infections / complications
Acinetobacter Infections / epidemiology
Acinetobacter Infections / microbiology
Acinetobacter Infections / prevention & control*
Baltimore / epidemiology
Disease Outbreaks
Humans
Intensive Care Units*
Methicillin Resistance*
Staphylococcal Infections / complications*
Staphylococcal Infections / microbiology
Staphylococcus aureus / drug effects
Staphylococcus aureus / isolation & purification*
Vancomycin Resistance*